tbuckley/cabot-search huggingface dataset:
THE FUNCTION OF THE CORPUS LUTEUM.
Journal: JAMA (1903)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
TCT CONNECT-417 Impact of Renal Denervation on Plasma Renin Activity and Relationship of Baseline Plasma Renin Activity to Blood Pressure Lowering Response to Renal Denervation in the SPYRAL HTN-OFF MED Pivotal trial
Authors: Felix Mahfoud, Raymond Townsend, David Kandzari, Kazuomi Kario, Roland Schmieder, Konstantinos Tsioufis, Michael Böhm, Stuart Pocock, Sidney Cohen, Martin Fahy, Michael Weber
Journal: Journal of the American College of Cardiology (2020)
Erratum: Estimated Exposure to Arsenic in Breastfed and Formula-Fed Infants in a United States Cohort
Journal: Environmental Health Perspectives (2015)

In the Abstract, the maximum urinary arsenic concentration was initially rounded to 3.0 µg/L and corrected to the value of 2.9 µg/L, and the median daily arsenic intake estimates for formula-fed and breastfed infants were transposed.In the Results section, the proportion of homes in the infant substudy with tap water > MCL was incorrectly reported as 2% instead of 1%.These errors have been corrected.In Figure 1, a few duplicate data points introduced by the software used to generate the figure have been removed.
Grooving of the great veins. Another, albeit indirect, sign of aortic dissection
Authors: I. Steinberg
Journal: JAMA (1968)

A new sign, grooving of the great veins, was recently encountered following the intravenous angiocardiographic study of a 61-year-old woman with dissecting aneurysm of the thoracic aorta. The deformity of the great veins, although an indirect sign, seems worthy of report.
Ethics
Authors: Edmund D. Pellegrino
Journal: JAMA (1996)

Thirty years ago, at the inception of the era of contemporary bioethics, the Hippocratic oath and the moral precepts it embodies were the immutable bedrock of medical ethics. They bound physicians in a moral community that reached across temporal, cultural, and national barriers. They seemed impervious even to the powerful scientific and societal forces then emerging. Today, those forces have made the oath and each of its precepts the subject of critical challenge. Revisionists judge them anachronistic and in need of radical revision or total abandonment. Traditionalists, as urgently, insist on their timelessness, restoration, and reaffirmation. On the eve of the 21st century, the future shape and the viability of the centuries-old tradition of medical ethics are seriously in question. What is at issue is the credibility and authority of the moral covenants that are at the heart of the oath, ie, the promises to act primarily for the benefit
Psoriatic Arthritis
Authors: Christopher T. Ritchlin, Robert A. Colbert, Dafna D. Gladman
Journal: New England Journal of Medicine (2017)

Psoriatic arthritis occurs in up to 30% of people with psoriasis and can have serious debilitating effects on the peripheral joints, spine, tendon insertions, and fingers. Management has improved, but complete disease control is not yet achievable.
BBS volume 7 issue 4 Cover and Back matter
Authors: Barbara Westergaard, Mary Laing, Anne Hebenstreit, E Loftus, G Hunt, E Broadbent, A Mackworth, M Martin, Morton Memory
Journal: Behavioral and Brain Sciences (1984)

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Lymphocyte Transformation
Authors: Suzanne Alexander
Journal: British Journal of Dermatology (1972)

Journal Article Lymphocyte Transformation Get access Suzanne Alexander Suzanne Alexander Department of Medicine Guy's Hospital Medical School London Bridge, S.E.I Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 86, Issue 1, 1 January 1972, Page 103, https://doi.org/10.1111/j.1365-2133.1972.tb01905.x Published: 01 January 1972
BOOKS RECEIVED
Journal: British Journal of Dermatology (1930)

Abstract Book received in this article: Diagnodica e Tecnica di Lahoratorio. Vol. I, No. 1. Gennaio. 1930 The Conquest. of Cancer by Radium and other Methods. By D. T. Quioley M.D Meine Diat. By Dr. Max Gerson The Cosmetic Treatment of Skin Complaints. Professor E. Kromayer Operationslose Krampfader-Behandlung. By Conrad Setbert und Ernst Wreszynski.
"STRONGYLOIDES INTESTINALIS INFESTATION"
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Limitations of the human organism. Analysis of world records and Olympic performance
Authors: A. B. Craig
Journal: JAMA (1968)

World records in a number of different sports constitute a large volume of extremely reliable and accurate data. As Hill<sup>1</sup>indicated, "Some of the most consistent physiological data are contained, not in books on physiology, not even in books on medicine, but in world records for running different horizontal distances." Analysis of running records has been attempted from several different points of view. Recently, Lloyd<sup>2</sup>discussed world marks of male runners in terms of available energy required to run from 50 yards to 623 miles. Lietske<sup>3</sup>introduced the idea that one could make a prediction of future running records from analysis of the present velocityduration curves, as discussed later in this communication. As indicated in another article,<sup>4</sup>Lietske's short-range forecasts proved amazingly accurate. Similar methods have been used to examine records in swimming<sup>4</sup>and weight lifting.<sup>5</sup> Particularly suitable for examination are athletic events in which
NKH477, a new inotropic reagent that directly stimulates adenylyl cyclase, does not cause the beta-adrenergic receptor downregulation; Demonstration using a newly developed whole cell binding assays Kousaku Iwatsubo, Yang Tao, Takeshi Onda, Yoshiyuki Toya, Takayuki Fujita, Satoshi Umemura, Yoshihiro Ishikawa. Yokohama City University, Yokohama, Japan, University of Medicine and Dentistry of New Jersey, Newark, NJ
Journal: Journal of the American College of Cardiology (2001)
In Reply:
Authors: Djillali Annane, Sylvie Chevret
Journal: Journal of Clinical Oncology (2005)

the study contains several minor and even major flaws.One of the minor flaws seems to be the incorrect citation of the study of Marx et al, 2 a randomized trial in which the use of HBO versus penicillin in the prevention of ORN is studied (and not HBO and penicillin v penicillin alone as the authors state).Furthermore, HBO treatment is given twice daily in the present study.This is in contrast with the majority of reports in the literature, in which once per day is the standard treatment.A major flaw, however, seems to be the fact that the studied group, patients with an ORN, is not well defined.In the literature, it is well recognized that the definition of osteoradionecrosis is difficult.Several authors have stressed this problem or even tried to make a classification. [3]][5][6][7] The inclusion criteria used in this report consisted of (1) one of the clinical criteria: pain, dysaesthesia in the distribution of the inferior alveolar nerve, areas of bone exposure, trismus, and fistula; and (2) one of the radiographic criteria: increased density, periosteal thickening, diffuse radiolucency, mottled areas of osteoporosis, and sclerosis sequestration.Of the clinical criteria, in the literature, only areas of bone exposure and fistula are generally recognized as criteria for osteoradionecrosis.The others are mere symptoms that may or may not occur.Of the radiographic criteria, only diffuse radiolucency in combination with bone exposure and sequestration are used as criteria.Many of the possible combinations as suggested by the authors, for instance, pain and increased density, trismus and mottled areas of osteoporosis, and other combinations, are not sufficient for a diagnosis of osteoradionecrosis.Therefore, the patient population as reported is not representative for patients with osteoradionecrosis of the mandible.This may furthermore be concluded from the data in Table 1, in which it seems that only approximately half of the patients show exposed bone-the most generally accepted criterion for osteoradionecrosis.In conclusion, we believe that the present population of patients do not represent a reproducible series of osteoradionecrosis of the mandible, meaning that no conclusions can be drawn from the outcomes of treatment.
American Red Cross Abridged Text-Book on First Aid: A Manual of Instruction Industrial Edition.
Journal: JAMA (1910)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Fellowships and Grants
Journal: JNCI Journal of the National Cancer Institute (1990)

Journal Article Fellowships and Grants Get access JNCI: Journal of the National Cancer Institute, Volume 82, Issue 21, 7 November 1990, Pages 1727–1728, https://doi.org/10.1093/jnci/82.21.1727 Published: 07 November 1990
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine
Authors: Aiden Haghikia, Stefanie Jörg, Alexander Duscha, Johannes Berg, Arndt Manzel, Anne Waschbisch, Anna Hammer, De-Hyung Lee, Caroline May, Nicola Wilck, Andras Balogh, Annika I. Ostermann, Nils Helge Schebb, Denis A. Akkad, Diana A. Grohme, Markus Kleinewietfeld, Stefan Kempa, Jan Thöne, Seray Demir, Dominik N. Müller, Ralf Gold, Ralf A. Linker
Journal: Immunity (2016)
Undergraduate medical education
Authors: H. S. Jonas
Journal: JAMA (1988)

<h3>INTRODUCTION</h3> In a time of exploding scientific and technological information, which parallels a period of profound change in societal attitudes toward the delivery of health care, the challenge to medical educators and their institutions has never been greater. Undergraduate medical education is confronted by an expanded knowledge base in the biomedical sciences and pressures to adjust the curriculum accordingly. In addition, in attempting to respond to changing social currents, with ethical dilemmas assuming a new magnitude, a renewed focus has occurred in the development of a proper balance between the art and the science of medicine. The system of undergraduate medical education in the United States consists of medical schools with a diversity of missions. This diversity, combined with a variety of innovations in undergraduate medical education, represents the considerable strength of our system. This annual report on undergraduate medical education in the United States during the 1987-1988 academic year
Abstract 5146: ATP-binding cassette transporter, ABCG2, activation is responsible for chemo-resistant, SIK3 low expressed ovarian cancer
Authors: Keng-Fu Hsu, Yu-Ling Liang, Chin-Han Wu, Neng-Yao Shih
Journal: Cancer Research (2019)

Abstract Background: Epithelial ovarian cancer (EOC) has a high tumor-associated mortality rate among the gynecological cancers because of chemo-resistant development. Materials and Method: The human EOC cell lines, SKOV3, OVRCA4, were obtained from the American Type Culture Collection (ATCC). For determine ATP-binding cassette transporters and SIK3 expression, Western blot and Quantitative real-time polymerase chain reaction (qRT-PCR) were used. We used a lentiviral small-hairpin RNA (shRNA) system to knock down SIK3 in the ovarian cancer cell lines. Microarray data derived from SKOV3, OVRCA4 cells expressing sh-luc, sh-SIK3 (01), and sh-SIK3 (63) were analyzed by MetaCore and Ingenuity Pathways Analysis (IPA). Top 10 up-and down-regulated genes and other metastasis-related genes and 5 most highly enriched networks were identified. For determining cell viability when cells treated with cisplatin and Taxol, WST-1 assay was used. Immunohistochemistry and quantification of ABCG2 and SIK3 were performed in EOC tissues. Statistical analysis of OS and PFS were performed using SPSS statistical software (Version 22.0; IBM Corp, Armonk, NY). Survival curves were generated using the Kaplan-Meier method, and differences in survival were assessed using the log-rank test. Results: Knockdown SIK3 expression upregulates ABCG2 expression, activity as well as resistance to chemotherapeutic agents. The ABCG2 and SIK3 expression levels in 204 EOC patient were mutually reversed. In all stages of the disease, high expression of SIK3 (SIK3-H) was associated with a significant better OS, PFS, compared with low expression of SIK3 (SIK3-L) (127.0 vs 46.0 months, 66.0 months vs 26.0 months respectively). Patients with SIK3-L and ABCG2-H carried the worst prognosis. Conclusion: (1) High expression of SIK3 indicates a better prognosis in primary ovarian cancer and serous type disease, especially in advanced serous disease. (2) Ovarian cancer patients with SIK3-L and ABCG2-H expression carried the worst prognosis due to chemoresistance Citation Format: Keng-Fu Hsu, Yu-Ling Liang, Chin-Han Wu, Neng-Yao Shih. ATP-binding cassette transporter, ABCG2, activation is responsible for chemo-resistant, SIK3 low expressed ovarian cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 5146.
The Radiologist
Authors: Enrique Pantoja
Journal: JAMA (1995)

The main goal of this journal is to review the literature for the practicing radiologist.<i>The Yearbook of Diagnostic Radiology</i>already provides this service with greater breadth but much less depth than<i>The Radiologist</i>, as observed in the three issues examined of this new journal.<i>Radiologic Clinics of North America</i>, with goals that overlap even more closely, compares favorably with<i>The Radiologist</i>in depth of coverage. Unlike<i>Clinics</i>, which devotes entire issues to a single topic,<i>The Radiologist</i>seems poised to target opportune topics in a timely fashion. This new journal therefore should be able to carve a niche for itself between these two competitors: closer to<i>Clinics</i>in depth of coverage, though somewhere between the two in breadth of subject matter. Each issue of<i>The Radiologist</i>contains five or six clinically oriented review articles that have been submitted by invitation and reviewed by the editorial board. The journal aims
Acute-on-chronic liver failure as defined by the European (EASL-CLIF) versus North American (NACSELD) diagnostic criteria in their prediction of short-term prognosis in patients with decompensated cirrhosis admitted into hospital
Authors: Florence Wong, Rajender Reddy, Puneeta Tandon, Jennifer Lai, Nishita Jagarlamudi, Beverley Kok, Sylvia Kalainy, Yanin Srisengfa, Somaya Albhaisi, Bradley Reuter, Chathur Acharya, Jawaid Shaw, Leroy Thacker, Jasmohan S Bajaj
Journal: Journal of Hepatology (2020)
ONCOPRE: A new chemotherapy benefit prediction model to assist treatment decision making.
Authors: Dimas Yusuf, Maria Yi Ho, Winson Y. Cheung
Journal: Journal of Clinical Oncology (2017)

126 Background: Clinical decision support tools (CDSTs) can help physicians make complex treatment decisions and inform care. For colon cancer, CDSTs such as Adjuvant! Online and Numeracy were widely used to estimate the effects of adjuvant treatment and guide conversations with patients. Existing CDSTs, however, do not consider more contemporary predictive and prognostic factors, such as microsatellite instability (MSI), BRAF mutational status, or the presence of additional high risk clinical or pathological features (HRFs), in their assessment of outcomes. Current CDSTs are also not optimized for handheld devices. Methods: We developed ONCOPRE, which is an adjuvant chemotherapy benefit calculator for colon cancer that addresses the limitations of current CDSTs. Based on a comprehensive review of epidemiological data and results of landmark trials, ONCOPRE was devised to predict 5 year colon cancer recurrence and death. To validate ONCOPRE, we compared its predictions with those generated by existing CDSTs as well as real-world data from 7 tertiary cancer centers across Canada. Results: ONCOPRE is able to predict 5-year DFS and OS of patients with colon cancer based on age, sex, TNM status, and contemporary risk factors such as MSI status, BRAF mutations, and other HRFs. ONCOPRE’s predictions compare favorably with real-world data and predictions from other CDSTs. ONCOPRE’s predictions are typically more optimistic than historical outcomes, and this likely reflects the fact that current day colon cancer patients experience better prognosis with the use of modern therapy and improved supportive care. These attributes make ONCOPRE a potentially new benchmark among CDSTs that can reliably predict colon cancer outcomes. Conclusions: ONCOPRE ( http://www.oncopre.com/ ) represents a new CDST that can assist in adjuvant treatment decision-making and patient counseling. We make the case that the next generation of CDSTs in oncology must take into account more contemporary clinical, biochemical, and genetic risk factors since these elements significantly affect outcomes. The ONCOPRE platform serves as a potential model on which to develop prediction tools for other forms of cancers.
Concomitant chemoradiotherapy.
Authors: A Aref
Journal: Journal of Clinical Oncology (1990)

Article Tools Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.1990.8.11.1928 Journal of Clinical Oncology - published online before print September 22, 2016 PMID: 2230884 Concomitant chemoradiotherapy. A ArefxA ArefSearch for articles by this author https://doi.org/10.1200/JCO.1990.8.11.1928 First Page PDF © 1990 by American Society of Clinical Oncology
LATENT PNEUMONIA.
Journal: JAMA (1902)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
American Society of Nephrology, 26th annual meeting. November 14-17, 1993. Abstracts.
Journal: Journal of the American Society of Nephrology (1993)

Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts Enter your Email address: Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. Subscribe to eTOC Secondary Logo Journal Logo All Articles Images Videos Podcasts Blogs Advanced Search Toggle navigation Subscribe Register Login Articles Current IssuePublished Ahead of Print Subject CollectionsPodcastsArchives Authors Submit to JASNInformation for Authors Journal Info About JASNEditorial TeamEditorial FellowsEditorial Fellowship ApplicationJASN ImpactJASN Recognizes More AlertsAdvertisingSubscriptionsReprints All Articles Images Videos Podcasts Blogs Advanced Search